Utah Medical Products (NASDAQ:UTMD) Share Price Passes Above 200 Day Moving Average - Time to Sell?

Key Points

• Utah Medical Products shares have surpassed their 200-day moving average of $56.88, peaking at $64.22 during trading before settling at $63.30.
• The company received a sell rating from Weiss Ratings, indicating cautious sentiment among analysts with a consensus rating of "Sell."
• Utah Medical Products recently announced a quarterly dividend of $0.305 per share, reflecting an annualized dividend yield of 1.9%.

Utah Medical Products, Inc. (NASDAQ:UTMD - Get Free Report) shares passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $56.88 and traded as high as $64.22. Utah Medical Products shares last traded at $63.30, with a volume of 5,331 shares traded.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a "sell (d+)" rating on shares of Utah Medical Products in a research report on Saturday, September 27th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has a consensus rating of "Sell".

Utah Medical Products Stock Down 0.9%

The company has a market cap of $202.94 million, a PE ratio of 16.93 and a beta of 0.32. The firm has a 50 day simple moving average of $60.26 and a 200-day simple moving average of $56.88.

Utah Medical Products (NASDAQ:UTMD - Get Free Report) last issued its quarterly earnings results on Thursday, July 24th. The medical instruments supplier reported $0.94 earnings per share for the quarter. Utah Medical Products had a return on equity of 10.55% and a net margin of 32.34%.The business had revenue of $9.95 million for the quarter.

Utah Medical Products Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, October 2nd. Investors of record on Wednesday, September 17th were issued a dividend of $0.305 per share. The ex-dividend date of this dividend was Wednesday, September 17th. This represents a $1.22 dividend on an annualized basis and a dividend yield of 1.9%. Utah Medical Products's payout ratio is 32.62%.

Institutional Investors Weigh In On Utah Medical Products

A number of institutional investors and hedge funds have recently modified their holdings of the company. Brandes Investment Partners LP lifted its holdings in shares of Utah Medical Products by 12.0% during the second quarter. Brandes Investment Partners LP now owns 271,322 shares of the medical instruments supplier's stock worth $15,444,000 after purchasing an additional 29,073 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Utah Medical Products by 6.5% during the second quarter. Geode Capital Management LLC now owns 114,816 shares of the medical instruments supplier's stock worth $6,537,000 after purchasing an additional 7,040 shares during the period. Hotchkis & Wiley Capital Management LLC lifted its holdings in shares of Utah Medical Products by 35.2% during the first quarter. Hotchkis & Wiley Capital Management LLC now owns 101,640 shares of the medical instruments supplier's stock worth $5,696,000 after purchasing an additional 26,460 shares during the period. Minerva Advisors LLC lifted its holdings in shares of Utah Medical Products by 7.1% during the second quarter. Minerva Advisors LLC now owns 93,058 shares of the medical instruments supplier's stock worth $5,267,000 after purchasing an additional 6,156 shares during the period. Finally, Bank of New York Mellon Corp lifted its holdings in Utah Medical Products by 2.7% in the first quarter. Bank of New York Mellon Corp now owns 48,612 shares of the medical instruments supplier's stock valued at $2,724,000 after acquiring an additional 1,277 shares during the period. Institutional investors and hedge funds own 69.60% of the company's stock.

Utah Medical Products Company Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.